Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Sarcopenia | Research

Utilize multi-metabolic parameters as determinants for prediction of skeletal muscle mass quality in elderly type2 diabetic Chinese patients

Authors: Huiling Chen, Jingjing Lou, Meiyuan Dong, Xintao Liu, Shijie Yan, Song Wen, Ligang Zhou, Xingdang Liu, Xinlu Yuan

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

Sarcopenia, an age-related disorder characterized by loss of skeletal muscle mass and function, is recently recognized as a complication in elderly patients with type 2 diabetes mellitus (T2DM). Skeletal muscles play a crucial role in glycemic metabolism, utilizing around 80% of blood glucose. Accordingly, we aimed to explore the relationship between glucose metabolism and muscle mass in T2DM.

Methods

We employed the AWGS 2019 criteria for diagnosing low muscle mass and 1999 World Health Organization (WHO) diabetes diagnostic standards. This study included data of 191 individuals aged 60 and above with T2DM of Shanghai Pudong Hospital from November 2021 to November 2022. Fasting C-peptide (FPCP), fasting plasma glucose (FPG), 2-hour postprandial plasma glucose (PPG) and postprandial 2-hour C-peptide (PPCP), glycated hemoglobin A1c (HbA1c), glycated albumin (GA), serum lipids spectrum, renal and hepatic function, hemoglobin, and hormone were measured. Based on the findings of univariate analysis, logistic regression and receiver operating characteristic (ROC) curves were established.

Results

Participants with low muscle mass had significantly lower alanine and aspartate aminotransferase, and both FPCP and PPCP levels (P < 0.05). Compared with those without low muscle mass, low muscle mass group had significantly higher FPG, HbA1c, GA levels (P < 0.05). Body fat (BF, OR = 1.181) was an independent risk factor for low muscle mass. PPCP (OR = 0.497), BMI (OR = 0.548), and female (OR = 0.050) were identified as protective factors for low skeletal muscle. The AUC of BMI was the highest, followed by the PPCP, gender and BF (0.810, 0.675, 0.647, and 0.639, respectively), and the AUC of the combination of the above four parameters reached 0.895.

Conclusions

In this cross-sectional study, BMI, Female, and PPCP associated with T2DM were protective factors for low muscle mass. BF was associated with T2DM and risk factor for low muscle mass.
Literature
1.
2.
go back to reference Sylow L, Tokarz VL, Richter EA, Klip A. The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia. Cell Metab. 2021;33(4):758–80.CrossRefPubMed Sylow L, Tokarz VL, Richter EA, Klip A. The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia. Cell Metab. 2021;33(4):758–80.CrossRefPubMed
4.
go back to reference Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of Sarcopenia in patients with type 2 diabetes: the Korean sarcopenic obesity study (KSOS). Diabetes Care. 2010;33(7):1497–9.CrossRefPubMedPubMedCentral Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of Sarcopenia in patients with type 2 diabetes: the Korean sarcopenic obesity study (KSOS). Diabetes Care. 2010;33(7):1497–9.CrossRefPubMedPubMedCentral
5.
go back to reference Izzo A, Massimino E, Riccardi G, Della Pepa G. A narrative review on Sarcopenia in type 2 diabetes Mellitus: Prevalence and Associated factors. Nutrients. 2021;13(1). Izzo A, Massimino E, Riccardi G, Della Pepa G. A narrative review on Sarcopenia in type 2 diabetes Mellitus: Prevalence and Associated factors. Nutrients. 2021;13(1).
6.
go back to reference Chung SM, Moon JS, Chang MC. Prevalence of Sarcopenia and its Association with diabetes: a Meta-analysis of Community-Dwelling Asian Population. Front Med (Lausanne). 2021;8:681232.CrossRefPubMed Chung SM, Moon JS, Chang MC. Prevalence of Sarcopenia and its Association with diabetes: a Meta-analysis of Community-Dwelling Asian Population. Front Med (Lausanne). 2021;8:681232.CrossRefPubMed
7.
go back to reference Liccini A, Malmstrom TK. Frailty and Sarcopenia as predictors of adverse health outcomes in persons with diabetes Mellitus. J Am Med Dir Assoc. 2016;17(9):846–51.CrossRefPubMed Liccini A, Malmstrom TK. Frailty and Sarcopenia as predictors of adverse health outcomes in persons with diabetes Mellitus. J Am Med Dir Assoc. 2016;17(9):846–51.CrossRefPubMed
8.
9.
go back to reference Takahashi F, Hashimoto Y, Kaji A, Sakai R, Okamura T, Kitagawa N, et al. Sarcopenia is Associated with a risk of mortality in people with type 2 diabetes Mellitus. Front Endocrinol (Lausanne). 2021;12:783363.CrossRefPubMed Takahashi F, Hashimoto Y, Kaji A, Sakai R, Okamura T, Kitagawa N, et al. Sarcopenia is Associated with a risk of mortality in people with type 2 diabetes Mellitus. Front Endocrinol (Lausanne). 2021;12:783363.CrossRefPubMed
10.
go back to reference Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic control and Insulin Improve Muscle Mass and Gait Speed in Type 2 diabetes: the MUSCLES-DM Study. J Am Med Dir Assoc. 2021;22(4):834–8e1.CrossRefPubMed Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic control and Insulin Improve Muscle Mass and Gait Speed in Type 2 diabetes: the MUSCLES-DM Study. J Am Med Dir Assoc. 2021;22(4):834–8e1.CrossRefPubMed
11.
go back to reference Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is Associated with impaired muscle quality in older men with diabetes: the Korean Longitudinal Study on Health and Aging. Diabetes Metab J. 2016;40(2):140–6.CrossRefPubMedPubMedCentral Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is Associated with impaired muscle quality in older men with diabetes: the Korean Longitudinal Study on Health and Aging. Diabetes Metab J. 2016;40(2):140–6.CrossRefPubMedPubMedCentral
12.
go back to reference Lopez Teros MT, Ramirez CF, Aleman-Mateo H. Hyperinsulinemia is associated with the loss of appendicular skeletal muscle mass at 4.6 year follow-up in older men and women. Clin Nutr. 2015;34(5):931–6.CrossRefPubMed Lopez Teros MT, Ramirez CF, Aleman-Mateo H. Hyperinsulinemia is associated with the loss of appendicular skeletal muscle mass at 4.6 year follow-up in older men and women. Clin Nutr. 2015;34(5):931–6.CrossRefPubMed
13.
go back to reference World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus [M]. Geneva: World Health Organization; 1999. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus [M]. Geneva: World Health Organization; 1999.
14.
go back to reference Visser M, Fuerst T, Lang T, Salamone L, Harris TB. Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study–Dual-Energy X-ray Absorptiometry and Body Composition Working Group. J Appl Physiol (1985). 1999;87(4):1513-20. Visser M, Fuerst T, Lang T, Salamone L, Harris TB. Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study–Dual-Energy X-ray Absorptiometry and Body Composition Working Group. J Appl Physiol (1985). 1999;87(4):1513-20.
16.
go back to reference Lv Y, Zheng Y, Zhao X, Li Z, Wang G. The relationship between islet beta-cell function and metabolomics in overweight patients with type 2 diabetes. Biosci Rep. 2023;43(2). Lv Y, Zheng Y, Zhao X, Li Z, Wang G. The relationship between islet beta-cell function and metabolomics in overweight patients with type 2 diabetes. Biosci Rep. 2023;43(2).
17.
go back to reference Bouchi R, Fukuda T, Takeuchi T, Nakano Y, Murakami M, Minami I, et al. Insulin treatment attenuates decline of muscle Mass in Japanese patients with type 2 diabetes. Calcif Tissue Int. 2017;101(1):1–8.CrossRefPubMedPubMedCentral Bouchi R, Fukuda T, Takeuchi T, Nakano Y, Murakami M, Minami I, et al. Insulin treatment attenuates decline of muscle Mass in Japanese patients with type 2 diabetes. Calcif Tissue Int. 2017;101(1):1–8.CrossRefPubMedPubMedCentral
18.
go back to reference Merchant RA, Seetharaman S, Au L, Wong MWK, Wong BLL, Tan LF, et al. Relationship of Fat Mass Index and Fat Free Mass Index with Body Mass Index and Association with function, cognition and Sarcopenia in Pre-frail older adults. Front Endocrinol (Lausanne). 2021;12:765415.CrossRefPubMed Merchant RA, Seetharaman S, Au L, Wong MWK, Wong BLL, Tan LF, et al. Relationship of Fat Mass Index and Fat Free Mass Index with Body Mass Index and Association with function, cognition and Sarcopenia in Pre-frail older adults. Front Endocrinol (Lausanne). 2021;12:765415.CrossRefPubMed
19.
go back to reference Yin M, Zhang H, Liu Q, Ding F, Hou L, Deng Y, et al. Determination of skeletal muscle mass by aspartate aminotransferase / alanine aminotransferase ratio, insulin and FSH in Chinese women with Sarcopenia. BMC Geriatr. 2022;22(1):893.CrossRefPubMedPubMedCentral Yin M, Zhang H, Liu Q, Ding F, Hou L, Deng Y, et al. Determination of skeletal muscle mass by aspartate aminotransferase / alanine aminotransferase ratio, insulin and FSH in Chinese women with Sarcopenia. BMC Geriatr. 2022;22(1):893.CrossRefPubMedPubMedCentral
20.
go back to reference Chen MJ, Leng J, Ni JP, Xiong AL, Hu MY. U-shaped association between plasma C-peptide and sarcopenia: a cross-sectional study of elderly Chinese patients with diabetes mellitus. PLoS ONE. 2023;18(10):e0292654.CrossRefPubMedPubMedCentral Chen MJ, Leng J, Ni JP, Xiong AL, Hu MY. U-shaped association between plasma C-peptide and sarcopenia: a cross-sectional study of elderly Chinese patients with diabetes mellitus. PLoS ONE. 2023;18(10):e0292654.CrossRefPubMedPubMedCentral
21.
go back to reference Giha HA, Alamin OAO, Sater MS. Diabetic Sarcopenia: metabolic and molecular appraisal. Acta Diabetol. 2022;59(8):989–1000.CrossRefPubMed Giha HA, Alamin OAO, Sater MS. Diabetic Sarcopenia: metabolic and molecular appraisal. Acta Diabetol. 2022;59(8):989–1000.CrossRefPubMed
23.
go back to reference de Freitas MM, de Oliveira VLP, Grassi T, Valduga K, Miller MEP, Schuchmann RA, et al. Difference in Sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol. 2020;132:110835.CrossRefPubMed de Freitas MM, de Oliveira VLP, Grassi T, Valduga K, Miller MEP, Schuchmann RA, et al. Difference in Sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol. 2020;132:110835.CrossRefPubMed
24.
go back to reference Sazlina SG, Lee PY, Chan YM, MS AH, Tan NC. The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia. PLoS ONE. 2020;15(5):e0233299.CrossRefPubMedPubMedCentral Sazlina SG, Lee PY, Chan YM, MS AH, Tan NC. The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia. PLoS ONE. 2020;15(5):e0233299.CrossRefPubMedPubMedCentral
25.
go back to reference Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1–7.CrossRefPubMed Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1–7.CrossRefPubMed
26.
go back to reference Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 2017;60(5):865–72.CrossRefPubMed Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 2017;60(5):865–72.CrossRefPubMed
27.
go back to reference Wu H, Liu M, Chi VTQ, Wang J, Zhang Q, Liu L, et al. Handgrip strength is inversely associated with metabolic syndrome and its separate components in middle aged and older adults: a large-scale population-based study. Metabolism. 2019;93:61–7.CrossRefPubMed Wu H, Liu M, Chi VTQ, Wang J, Zhang Q, Liu L, et al. Handgrip strength is inversely associated with metabolic syndrome and its separate components in middle aged and older adults: a large-scale population-based study. Metabolism. 2019;93:61–7.CrossRefPubMed
28.
go back to reference Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67–81.CrossRefPubMed Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67–81.CrossRefPubMed
29.
go back to reference Nishikawa H, Fukunishi S, Asai A, Yokohama K, Ohama H, Nishiguchi S et al. Sarcopenia, frailty and type 2 diabetes mellitus (review). Mol Med Rep. 2021;24(6). Nishikawa H, Fukunishi S, Asai A, Yokohama K, Ohama H, Nishiguchi S et al. Sarcopenia, frailty and type 2 diabetes mellitus (review). Mol Med Rep. 2021;24(6).
30.
go back to reference Larsson L, Orlander J. Skeletal muscle morphology, metabolism and function in smokers and non-smokers. A study on smoking-discordant monozygous twins. Acta Physiol Scand. 1984;120(3):343–52.CrossRefPubMed Larsson L, Orlander J. Skeletal muscle morphology, metabolism and function in smokers and non-smokers. A study on smoking-discordant monozygous twins. Acta Physiol Scand. 1984;120(3):343–52.CrossRefPubMed
31.
go back to reference Wust RC, Morse CI, de Haan A, Rittweger J, Jones DA, Degens H. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol. 2008;104(1):103–10.CrossRefPubMedPubMedCentral Wust RC, Morse CI, de Haan A, Rittweger J, Jones DA, Degens H. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol. 2008;104(1):103–10.CrossRefPubMedPubMedCentral
32.
go back to reference Degens H, Veerkamp JH. Changes in oxidative capacity and fatigue resistance in skeletal muscle. Int J Biochem. 1994;26(7):871–8.CrossRefPubMed Degens H, Veerkamp JH. Changes in oxidative capacity and fatigue resistance in skeletal muscle. Int J Biochem. 1994;26(7):871–8.CrossRefPubMed
33.
go back to reference Orlander J, Kiessling KH, Larsson L. Skeletal muscle metabolism, morphology and function in sedentary smokers and nonsmokers. Acta Physiol Scand. 1979;107(1):39–46.CrossRefPubMed Orlander J, Kiessling KH, Larsson L. Skeletal muscle metabolism, morphology and function in sedentary smokers and nonsmokers. Acta Physiol Scand. 1979;107(1):39–46.CrossRefPubMed
34.
go back to reference Degens H, Gayan-Ramirez G, van Hees HW. Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms. Am J Respir Crit Care Med. 2015;191(6):620–5.CrossRefPubMed Degens H, Gayan-Ramirez G, van Hees HW. Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms. Am J Respir Crit Care Med. 2015;191(6):620–5.CrossRefPubMed
35.
36.
go back to reference Rubin E, Katz AM, Lieber CS, Stein EP, Puszkin S. Muscle damage produced by chronic alcohol consumption. Am J Pathol. 1976;83(3):499–516.PubMedPubMedCentral Rubin E, Katz AM, Lieber CS, Stein EP, Puszkin S. Muscle damage produced by chronic alcohol consumption. Am J Pathol. 1976;83(3):499–516.PubMedPubMedCentral
38.
go back to reference Essid SM, Bevington A, Brunskill NJ. Proinsulin C-Peptide enhances cell survival and protects against Simvastatin-Induced myotoxicity in L6 rat myoblasts. Int J Mol Sci. 2019;20(7). Essid SM, Bevington A, Brunskill NJ. Proinsulin C-Peptide enhances cell survival and protects against Simvastatin-Induced myotoxicity in L6 rat myoblasts. Int J Mol Sci. 2019;20(7).
Metadata
Title
Utilize multi-metabolic parameters as determinants for prediction of skeletal muscle mass quality in elderly type2 diabetic Chinese patients
Authors
Huiling Chen
Jingjing Lou
Meiyuan Dong
Xintao Liu
Shijie Yan
Song Wen
Ligang Zhou
Xingdang Liu
Xinlu Yuan
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Sarcopenia
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04827-3

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine